✦ LIBER ✦

Management of relapsed diffuse large B-cell lymphoma

✍ Scribed by Vaishalee Padgaonkar Kenkre; Sonali M. Smith

Book ID: 107546626
Publisher: Current Science Inc.
Year: 2008
Tongue: English
Weight: 338 KB
Volume: 10
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-008-0061-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Late relapse in patients with diffuse la

Late relapse in patients with diffuse large B-cell lymphoma

✍ Julie M. Vose; Dennis D. Weisenburger; Fausto R. Loberiza; Alejandro Arevalo; Ma 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

Symptomatic intracardiac diffuse large B

Symptomatic intracardiac diffuse large B-cell lymphoma

✍ Makiko Ban-Hoefen; Steven H. Bernstein; John D. Bisognano; Jennifer G. Pryor; Jo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

Primary pulmonary diffuse large B-cell l

Primary pulmonary diffuse large B-cell lymphoma

✍ Tomasz Wróbel; Justyna Dzietczenia; Monika Prochorec–Sobieszek; Grzegorz Mazur; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

Anti-lymphoma effect of naproxen and ind

Anti-lymphoma effect of naproxen and indomethacin in a patient with relapsed diffuse large B-cell lymphoma

✍ Kentaro Yoshinaga; Masanao Teramura; Koji Iwabe; Shoko Kobayashi; Michihiko Masu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

Non-myeloablative allogeneic haematopoie

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience

✍ Andrew R. Rezvani; Lalitha Norasetthada; Ted Gooley; Mohamed Sorror; Michelle E. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Prognostic models for diffuse large b-ce

Prognostic models for diffuse large b-cell lymphoma

✍ Annarita Conconi; Emanuele Zucca; Enrico Roggero; Francesco Bertoni; Augusto Ber 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Prognosis of DLCL patients is variable and associated with well-de®ned risk factors. In the past decade several pretreatment variables have been incorporated into prognostic models to predict the death risk of individual patients. The International Prognostic Index (IPI), developed in an internation